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with a poor lipid profile, including decreased HDL-C and increased triglycerides (Chelland et al. 2008) . Here, we assess the influence of smoking as a modifier of known lipid-related genotype-phenotype associations across four racial/ethnic groups.
Study samples were drawn from the Population Architecture Using Genomics and Epidemiology (PAGE) study, which consists of four population-based studies and numerous racial/ethnic populations, including those examined here: European Americans (n = 24,700), African Americans (n = 9,782), American Indians (n = 3,607), and Mexican Americans/Hispanics (n = 3,357) (Matise et al. 2011) . Mean lipid levels by population and self-reported smoking status (dichotomized into current and former/never smokers) for all PAGE participants are listed in Table 1 . Study specific demographics are presented in Table S1 .
A total of 49 SNPs (Table S2 ) previously associated with one or more lipid trait in published (as of 2008) candidate gene and GWA studies were selected and successfully genotyped in PAGE (Dumitrescu et al. 2011) . Regression modeling was used to assess the effect of a multiplicative interaction between each variant and smoking status on HDL-C, LDL-C, and ln(TG) levels. Race-specific models were adjusted for age, sex, and marginal effects. Analyses were performed by each PAGE study site and summary statistics were meta-analyzed using METAL (Willer et al. 2010) . Given that the lipid traits are correlated and the associations tested are not assumed to be completely independent, significance was defined as p < 1.0E−03 to account for the 49 SNPs tested (=0.05/49 SNPs). Effect sizes needed to detect significant interactions with 80 % power were calculated using Quanto (Gauderman and Morrison 2006) . Variant main effect sizes used in the power calculation were drawn from a previous single-SNP association analysis for LDL-C (Dumitrescu et al. 2011) .
No significant SNP × smoking interactions were detected (Fig. 1) one population; however, the direction of effect was inconsistent (p = 1.35E−02, β = −0.031 in European Americans; p = 6.84E−03, β = 0.106 in Mexican Americans/ Hispanics). Several reasons may underlie the lack of significant interactions. First, not all PAGE study sites collected sufficient data to assess smoking status as recommended by harmonization work groups such as the consensus measures for phenotypes and eXposures [PhenX; (Hamilton et al. 2011)] . Additionally, quantitative measures of smoking exposure such as serum cotinine levels or number of pack-years, were not available for all PAGE study sites. Therefore, our binary categorization of smoking (though a commonly used metric of exposure) may have inhibited our ability to detect existing interactions.
Second, our power to detect to small interaction effects was limited, especially in minority populations and for variants with low minor allele frequencies (examples in Table 2 ). For example, we had 80 % power to detect a minimum interaction beta of 3.5 in European Americans, 5.0 in African Americans, 7.4 in American Indians, and 9.4 in Mexican Americans/Hispanics for HMGCR rs12654264 (allele frequency = 0.55-0.62). However, the effect sizes needed to detect a significant interaction with PCSK9 rs11591147 (allele frequency = 0.004-0.02) were four to seven times larger than those needed for rs12654264, despite the fact that the main effect of rs11591147 size was very large (β G = −15.67 to 23.39 mg/dl; Dumitrescu et al. 2011) .
Another factor that has implications for power is the range of smoking prevalence, both across (Table 1) and within (Table S1 ) racial/ethnic groups. All other measures being equal, increased prevalence of the environmental exposure results in increased power to detect a geneenvironment interaction. The populations studied here demonstrated a range of smoking exposures, with American Indians (33.7 %) having the largest percentage of current smokers and Mexican Americans/Hispanics having the smallest (16.9 %). As one can see from Table 2 , we were powered to detect smaller interaction effect sizes in American Indians compared to Mexican Americans/Hispanics for all four modeled interactions. Therefore, when designing gene-environment interaction studies, even larger sample sizes may be necessary for populations in which the environmental exposure is rare.
Last, the lack of significant interactions may simply be due to the fact that none exists for the variants and populations studied here. However, for some interactions, it is impractical to draw this conclusion given we cannot distinguish between a true negative and a false negative due to lack of statistical power.
Despite the known impact of smoking on lipids and the relevant role of the loci studied here in lipid metabolism, we were unable to identify significant SNP × smoking interactions. We demonstrate that studies of gene-environment interactions require very large sample sizes, greatly impeding the investigation of minority populations and complex environmental exposures.
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